| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | Options Exercise | $79,298 | +2,118 | +12% | $37.44 | 19,404 | 04 Mar 2022 | Direct | |
| transaction | EOG | Common Stock | Disposed to Issuer | $79,299 | -660 | -3.4% | $120.15 | 18,744 | 04 Mar 2022 | Direct | |
| transaction | EOG | Common Stock | Tax liability | $42,773 | -356 | -1.9% | $120.15 | 18,388 | 04 Mar 2022 | Direct | |
| transaction | EOG | Common Stock | Sale | $132,395 | -1,102 | -6% | $120.14 | 17,286 | 04 Mar 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -2,118 | -33% | $0.000000 | 4,244 | 04 Mar 2022 | Common Stock | 2,118 | $37.44 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. |